Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
04:45pm, Thursday, 03'rd Nov 2022 MarketWatch
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billion.
Moderna stock tumbles after quarterly earnings show revenue declines
04:05pm, Thursday, 03'rd Nov 2022
COVID-19 vaccine maker Moderna's shares fell on Thursday following the release of the company's third-quarter earnings, which showed a decline in revenue.
Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook
03:04pm, Thursday, 03'rd Nov 2022
Moderna's (MRNA) third-quarter earnings miss expectations, while sales narrowly beat the mark. Shares declined in pre-market trading after management announced a guidance cut in COVID vaccine sales.
Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
02:02pm, Thursday, 03'rd Nov 2022 MarketWatch
The global tally of COVID cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in its weekly update on the virus.
Moderna, Inc. (MRNA) Q3 2022 Earnings Call Transcript
11:44am, Thursday, 03'rd Nov 2022
Moderna, Inc. (NASDAQ:MRNA ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Lavina Talukdar – Head-Investor Relations Stéphane Bancel – Chief Executive Officer
Moderna misses on earnings as supply constraints hinder COVID vaccine deliveries
11:35am, Thursday, 03'rd Nov 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss third-quarter earnings for Moderna.
Global tally of COVID cases and deaths continues to fall; Moderna cuts vaccine-sales outlook by up to $3 billion
11:02am, Thursday, 03'rd Nov 2022
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in its weekly update on the virus.
Fear & Greed Index Remains In 'Greed' Zone After Fed Hikes Rates
10:45am, Thursday, 03'rd Nov 2022 Benzinga
The CNN Money Fear and Greed index remained in the "Greed" zone after US stocks recorded sharp losses on Wednesday.
The Fed announced another 0.75 percentage point rate hike on Wednesday. Federal Rese
Moderna (MRNA) Lags Q3 Earnings Estimates
09:50am, Thursday, 03'rd Nov 2022
Moderna (MRNA) delivered earnings and revenue surprises of -16.78% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Moderna (MRNA) Stock Down 5% Today?
09:40am, Thursday, 03'rd Nov 2022
Moderna (NASDAQ: MRNA ) stock is falling on Thursday following the release of the vaccine company's earnings report for the third quarter of 2022. The bad news for investors in MRNA stock starts with
Moderna tanks 14% after COVID-19 vaccine maker cuts yearly sales outlook and misses 3rd-quarter expectations
09:20am, Thursday, 03'rd Nov 2022
Short-term supply constraints led Moderna to cut its 2022 revenue outlook to a range of $18 billion to $19 billion.
Moderna stock slides 11.5% premarket after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
08:19am, Thursday, 03'rd Nov 2022
Moderna Inc. shares plunged 11% in premarket trade Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billi
Moderna Stock Tumbles on Earnings Miss, Guidance Cut
07:42am, Thursday, 03'rd Nov 2022
The Covid-19 vaccine maker reported earnings early Thursday that missed Wall Street estimates, while cutting its estimate of total vaccine sales this year by between $2 and $3 billion.
Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook
07:30am, Thursday, 03'rd Nov 2022
Moderna also missed revenue and earnings expectations for the quarter.
Why Moderna Stock Rose Today
06:55pm, Tuesday, 01'st Nov 2022
A rival drugmaker sees higher COVID-related sales ahead.
